Cystic fibrosis population carrier screening: Here at last - Are we ready?

Genetics in Medicine

Volumn 3, Issue 2, 2001, Pages 87-90

  Grody, Wayne W ^a   Desnick, Robert J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; NUCLEOTIDE;

AUTOSOMAL RECESSIVE DISORDER; CAREGIVER; CAUSE OF DEATH; CLONING; CYSTIC FIBROSIS; DISEASE CARRIER; DISEASE SEVERITY; EDITORIAL; ETHNIC AND RACIAL GROUPS; ETHNIC DIFFERENCE; FAMILY HISTORY; GENE; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENETIC COUNSELING; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HEALTH CARE COST; HEALTH EDUCATION; HEMOCHROMATOSIS; HETEROZYGOSITY; HUMAN; IRON OVERLOAD; LIFE EXPECTANCY; MALE INFERTILITY; MASS SCREENING; MECONIUM ILEUS; NORTH AMERICA; PANCREAS INSUFFICIENCY; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PROGNOSIS; PUBLIC HEALTH; SENSITIVITY AND SPECIFICITY; SOCIOECONOMICS;

EID: 0035746534     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/00125817-200103000-00001     Document Type: Editorial

References (32)

1. Cystic fibrosis
2. Identification of the cystic fibrosis gene: Chromosome walking and jumping
3. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
4. Identification of the cystic fibrosis gene: Genetic analysis
5. Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%
6. Complete detection of mutations in cystic fibrosis of Native American origin
7. Tay-Sachs disease: Carrier screening, diagnosis, and the molecular era - An international perspective
8. Prenatal genetic carrier testing using triple disease screening
9. Correlation between genotype and phenotype in patients with cystic fibrosis
10. Congenital bilateral absence of the vas deferens: A primarily genital form of cystic fibrosis
11. Diversity of cystic fibrosis mutation screening practices
12. Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening
13. Issues in implementing prenatal screening for cystic fibrosis: Results of a working conference
14. PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population
15. Cystic fibrosis heterozygote screening in 5,161 pregnant women
16. Couple-based prenatal screening for cystic fibrosis in primary care settings
17. Offering cystic fibrosis carrier screening to an HMO population: Factors associated with utilization
18. Cystic fibrosis carrier population screening in the primary care setting
19. Genetic testing for cystic fibrosis
20. Screening for cystic fibrosis carrier state
21. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening
22. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens
23. A mutation in CFTR produces different phenotypes depending on chromosomal background
24. High frequency of the R117H cystic fibrosis mutation in patients with congenital absence of the vas deferens
25. ASHG Presidential Address: Making genomic medicine a reality
26. Phenotypes of patients with "simple" Mendelian disorders are complex traits: Thresholds, modifiers, and systems dynamics
27. Modifier genes convert "simple" Mendelian disorders to complex traits
28. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation
29. Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria
30. Haemochromatosis, HFE, and genetic complexity
31. Hereditary hemochromatosis: Impact of molecular and iron-based testing on diagnosis, treatment, and prevention of a common chronic disease